Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00138284

Ligand	Ligand name	Chain	PDB	Tanimoto
3QC	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	A,B	2FME	0.79
HXS	4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol	A,B	3CV6	0.71
Y13	(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE	A	2EW6	0.72
AED	4-(2-aminoethyl)-2-cyclohexylphenol	A	3BUH	0.71
TNC	4-DIMETHYLAMINO-1,10,11,12-TETRAHYDROXY-3-OXO-3,4,4A,5-TETRAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE	A,B	1N5Q	0.74
099	(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide	A,B	3HYG	0.75
AOE	N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)-3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-7-YL]-N-METHYLUNDECANAMIDE	A	1HJ1	0.81
EQU	EQUILENIN	A,B	1OGX	0.73
EQU	EQUILENIN	A,B,C,D,E,F	1QJG	0.73
EQU	EQUILENIN	A,B	1OH0	0.73
EQU	EQUILENIN	A	1W6Y	0.73
EQU	EQUILENIN	A,B	1CQS	0.73
EQU	EQUILENIN	A	1OGZ	0.73
EQU	EQUILENIN	A	1GS3	0.73
EQU	EQUILENIN	A	1OHO	0.73
4SR	(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE	A,B	1XN0	0.71
IFB	N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE	A,B	3FCB	0.7
ARY	ARYLOMYCIN A2	A,B	1T7D	0.72
BJH	1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID	A	1ERQ	0.72
ROL	ROLIPRAM	A,B,C,D	1OYN	0.71
ROL	ROLIPRAM	A,B	1XMY	0.71
ROL	ROLIPRAM	A,B,C,D	1Q9M	0.71
ROL	ROLIPRAM	A,B	1RO6	0.71
ROL	ROLIPRAM	A,B	1XN0	0.71
ROL	ROLIPRAM	A,B	1TBB	0.71
EQI	EQUILIN	A,B	1EQU	0.72
SD2	N-(SULFANYLACETYL)TYROSYLPROLYLMETHIONINAMIDE	A,B	1PWQ	0.71
1BA	4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE	A	2GPP	0.73
TYP	CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR	A,B	1W1Y	0.74
ZYA	BENZOYL-TYROSINE-ALANINE-METHYL KETONE	A	1AIM	0.71
BM4	3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl-3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan-3-yl]phenol	X	2W6C	0.75
WH6	2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid	A,B	2R9X	0.7
098	(3R)-N~2~-(cyclopropylmethyl)-N~1~-hydroxy-3-(3-hydroxybenzyl)-N~4~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-L-aspartamide	A,B	3HY9	0.71
SDT	3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione	A,B	2ZI8	0.71
C1N	N-[(BENZYLOXY)CARBONYL]LEUCYL-N~1~-[3-FLUORO-1-(4-HYDROXYBENZYL)-2-OXOPROPYL]LEUCINAMIDE	A	1ZCM	0.7
SGI	3-(4-hydroxyphenyl)propanamide	A,B	2R9K	0.72
R12	9-(4-HYDROXY-2,6-DIMETHYL-PHENYL)-3,7-DIMETHYL-NONA-4,6,8-TRIENOIC ACID	A	3CBS	0.71
DK2	2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID	A,B	2PU2	0.76
OAC	TRANS-O-HYDROXY-ALPHA-METHYL CINNAMATE	C	3GCH	0.71
NLT	N-DODECANOYL-L-TYROSINE	A,B,C,D,E,F,G,H	2G0B	0.73
YTT	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	A	3G5H	0.74
DAI	(3AS,9AS)-2-PENTYL-4-HYDROXYMETHYL-3A,4,9,9A-TETRAHYDRO-4,9[1',2']-BENZENO-1H-BENZ[F]ISOINDOLE-1,3(2H)-DIONE	A,B,C,D	1YLS	0.73
DAI	(3AS,9AS)-2-PENTYL-4-HYDROXYMETHYL-3A,4,9,9A-TETRAHYDRO-4,9[1',2']-BENZENO-1H-BENZ[F]ISOINDOLE-1,3(2H)-DIONE	A,B,C,D	1YKV	0.73
BJP	(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID	A	1ERO	0.71
PY9	4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol	A,B	3EKR	0.8